Changes in toll-like receptor (TLR)4–NFκB–IL1β signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis-Reference-Cited by-同舟云学术

Changes in toll-like receptor (TLR)4–NFκB–IL1β signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis

Published:2013-09-14 Issue:2 Volume:34 Page:213-220
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Qing Yu-Feng,Zhang Quan-Bo,Zhou Jing-Guo,Jiang Li

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-013-2856-3.pdf

Reference32 articles.

1. Richette P, Bardin T (2010) Gout. Lancet 375:318–328

2. Baker JF, Schumacher HR (2010) Update on gout and hyperuricemia. Int J Clin Pract 64:371–377

3. Weaver AL (2008) Epidemiology of gout. Clevel Clin J Med 75:S9–12

4. Miao Z, Li C, Chen Y et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864

5. Annemans L, Spaepen E, Gaskin M et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WN1703 alleviates gout symptoms via inflammatory signaling pathways in an acute gout rat model;Pharmaceutical Science Advances;2024-12

2. Antigout effects and mechanisms of total flavonoids from prunus tomentosa;Technology and Health Care;2024-05-31

3. Mild hyperthermia enhanced synergistic uric acid degradation and multiple ROS elimination for an effective acute gout therapy;Journal of Nanobiotechnology;2024-05-22

4. Deficiency of histone deacetylases 3 in macrophage alleviates monosodium urate crystals-induced gouty inflammation in mice;Arthritis Research & Therapy;2024-05-06

5. Pathogenesis of gout: Exploring more therapeutic target;International Journal of Rheumatic Diseases;2024-04